Can emapalumab be life saving for refractory, recurrent, and progressive cytokine storm caused by COVID-19, which is resistant to anakinra, tocilizumab, and Janus kinase inhibitors

Although many potent drugs have been used for cytokine storm, mortality is high for patients with coronavirus disease-2019 (COVID-19), which is followed up in the intensive care unit. Interferons (IFNs) are the major cytokines of the antiviral defense system released from many cell types. However, I...

Descripción completa

Detalles Bibliográficos
Autores principales: Cure, Erkan, Kucuk, Adem, Cure, Medine Cumhur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262416/
https://www.ncbi.nlm.nih.gov/pubmed/34169908
http://dx.doi.org/10.4103/ijp.IJP_615_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262416/
https://www.ncbi.nlm.nih.gov/pubmed/34169908
http://dx.doi.org/10.4103/ijp.IJP_615_20

Ejemplares similares